Radio
Now Playing
Quickyla Radio โ€” Click to play
Open โ†’
3 min left
Back to News

Studies show Ozempic and Mounjaro may improve brain health in obese patients

Studies indicate that weight loss drugs Ozempic and Mounjaro may enhance brain health, particularly in individuals with obesity or diabetes, by potentially lowering dementia risk. However, while promโ€ฆ

Ozempic and Mounjaro may have a surprising effect on your brain
ScienceDaily โ€” 17 November 2026
Text:
1 0 0

Recent studies suggest that weight loss drugs like Ozempic and Mounjaro might have a positive impact on brain health beyond their primary purpose of aiding weight loss. These medications, which are part of a class known as GLP-1 receptor agonists, are gaining attention for their potential to influence cognitive function, particularly in individuals with obesity or diabetes.

The interest in these drugs stems from emerging evidence linking GLP-1 medications to a reduced risk of dementia. However, significant clinical trials have shown that semaglutide, one of the main ingredients in Ozempic, did not appear to slow the progression of Alzheimer's disease. This mixed evidence has prompted researchers to explore how these medications might better support memory and cognitive abilities in patients who have not yet experienced significant cognitive decline.

Experts believe that the benefits of these drugs may be most pronounced in individuals who are obese or diabetic. By addressing weight and metabolic health early, GLP-1 medications could help protect against cognitive decline before symptoms arise. This preventive approach is particularly important, as obesity and diabetes are known risk factors for developing dementia later in life.

As research continues, the implications of these findings could reshape how doctors approach obesity and cognitive health. If Ozempic and Mounjaro prove effective in preserving cognitive function, they may not only become staples in weight management but also in the broader strategy of preventing neurodegenerative diseases. This dual benefit could lead to greater interest in and accessibility of these drugs for at-risk populations.

Read Full Story at ScienceDaily โ†’
Advertisement
React:
Sources
Sponsored

More to Read

Researchers identify brain mechanism linking fear to anxietโ€ฆ
๐Ÿฅ Health
Researchers identify brain mechanism linking fear to anxiety and PTSD
ScienceDaily ยท 14 days ago
Welsh government proposes ban on energy drinks for under-16s
๐Ÿฅ Health
Welsh government proposes ban on energy drinks for under-16s
BBC Health ยท 11 days ago
Aadvik Jain, 18, receives Diana Award for menstrual health โ€ฆ
๐Ÿฅ Health
Aadvik Jain, 18, receives Diana Award for menstrual health activism in Delhi.
NPR News ยท 10 days ago
T-Mobile, AT&T, Verizon offer $1,200 off iPhone Duo with coโ€ฆ
๐Ÿ’ป Technology
T-Mobile, AT&T, Verizon offer $1,200 off iPhone Duo with contracts
Wired ยท 14 days ago
Nutritionists warn against late-night snacking for weight gโ€ฆ
๐Ÿฅ Health
Nutritionists warn against late-night snacking for weight gain risk
BBC Health ยท 12 days ago
XTEINK X4 Pro e-reader drops to record low price of $79
๐Ÿ’ป Technology
XTEINK X4 Pro e-reader drops to record low price of $79
Android Authority ยท 14 days ago
Full view